Across TCGA pan-cancer cohorts, MIR602 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR602’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR602 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR602 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

BLCA, STAD, and HNSC are the cancer types where MIR602 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR602 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	III,IV	+0.641	.016	3	view →
STAD	All	II,III,IV	+0.304	.009	3	view →
HNSC	All	III,IV	+0.210	.009	3	view →
THCA	All	All	−0.371	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR602 RNA expression & survival · all MIR602 data types